India and EU have decided to set up a working group on pharmaceuticals and biotechnology and both the sides have agreed to hold experts meetings soon. The meetings will be held with the participation of European Agency for Evaluation of Medicinal Products (EMEA) on the EU regulatory approach in the field of Ayurveda products.

Exchange information on the regulatory framework, on best practice in funding, research, environmental issues, technical exchange programmes and infrastructure support institutions will be initiated.

Both the sides will cooperate on confronting global challenges posed by diseases such as HIV/AIDS, TB and malaria, and as part of this seek to organise a conference on development of vaccines for HIV / AIDS, malaria and TB.

The ministry has sought industry suggestions on the areas of co-operation in the proposed fields, which can help the working group to focus on relevant issues of the industries.